Cortical hypometabolism in Parkinson’s disease is linked to cholinergic basal forebrain atrophy
- 5 December 2024
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (6) , 2372-2380
Abstract
Cortical hypometabolism on FDG-PET is a well-established neuroimaging biomarker of cognitive impairment in Parkinson’s disease (PD), but its pathophysiologic origins are incompletely understood. Cholinergic basal forebrain (cBF) degeneration is a prominent pathological feature of PD-related cognitive impairment and may contribute to cortical hypometabolism through cholinergic denervation of cortical projection areas. Here, we investigated in-vivo associations between subregional cBF volumes on 3T-MRI, cortical hypometabolism on [18F]FDG-PET, and cognitive deficits in a cohort of 95 PD participants with varying degrees of cognitive impairment. We further assessed the spatial correspondence of the cortical pattern of cBF-associated hypometabolism with the pattern of cholinergic denervation in PD as assessed by [18F]FEOBV-PET imaging of presynaptic cholinergic terminal density in a second cohort. Lower volume of the cortically-projecting posterior cBF, but not of the anterior cBF, was significantly associated with extensive neocortical hypometabolism [p(FDR) < 0.05], which mediated the association between cBF atrophy and cognitive impairment (mediated proportion: 43%, p < 0.001). In combined models, posterior cBF atrophy explained more variance in cortical hypometabolism (R2 = 0.26, p < 0.001) than local atrophy in the cortical areas themselves (R2 = 0.16, p = 0.01). Topographic correspondence analysis with the [18F]FEOBV-PET pattern revealed that cortical areas showing most pronounced cBF-associated hypometabolism correspond to those showing most severe cholinergic denervation in PD (Spearman’s ρ = 0.57, p < 0.001). In conclusion, posterior cBF atrophy in PD is selectively associated with hypometabolism in denervated cortical target areas, which mediates the effect of cBF atrophy on cognitive impairment. These data provide first-time in-vivo evidence that cholinergic degeneration represents a principle pathological correlate of cortical hypometabolism underlying cognitive impairment in PD.Keywords
This publication has 67 references indexed in Scilit:
- Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyJAMA Neurology, 2024
- Atrophy of the Cholinergic Basal Forebrain can Detect Presynaptic Cholinergic Loss in Parkinson's DiseaseAnnals of Neurology, 2023
- Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumJAMA Neurology, 2022
- Association of PICALM with Cognitive Impairment in Parkinson's DiseaseMovement Disorders, 2020
- Pathological Influences on Clinical Heterogeneity in Lewy Body DiseasesMovement Disorders, 2019
- The corticotopic organization of the human basal forebrain as revealed by regionally selective functional connectivity profilesHuman Brain Mapping, 2018
- Global scales for cognitive screening in Parkinson's disease: Critique and recommendationsMovement Disorders, 2017
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networksHuman Brain Mapping, 2015
- Parkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's diseaseMovement Disorders, 2008